Defining Optimal Immunotherapies for Type 1 Diabetes
Defining Optimal Immunotherapies for Type 1 Diabetes
Gregory R. Bock
,
Jamie A. Goode
Details
OL Work ID
OL21427579W
Find this book
Open Library